-
corporate objectives within established budgets. Has primary responsibility to monitor product cost by controlling BOM and process changes impacting cost or overall performance. Owns the strategic plan
-
regulations Independently conducts wide range of routine/(non-routine) complex investigator site audits (minimal to no oversight - as needed) Executes audit strategy, leads/supports process audits, and may
-
throughout the labeling review and approval process through notification to stakeholders in order to ensure that these documents are produced in a timely manner according to internal SOPs and external
-
collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact. PHYSICAL/MENTAL REQUIREMENTS This position/role works
-
. Strong understanding of the drug development process and regulatory submissions. Proficiency in Microsoft Office applications (Word, PowerPoint) and collaborative authoring tools (Endpoint, Starting Point
-
experience in Automation Engineering Experience with process controls equipment; design and debugging skills Broad understanding of systems architecture and operations, and related components Excellent project
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. ROLE SUMMARY This position will provide statistical support for
-
May manage the study start up process in countries assigned (where SUPM not assigned) and/or oversee pCRO responsible for these activities as applicable Through the Site Care Partner/Country Trial
-
cutting edge design and process development capabilities to accelerate and bring the best - in - class medicines to patients around the world. What You Will Achieve In your role, you will be at the center
-
into actionable insights. PHYSICAL/MENTAL REQUIREMENTS Must be able to travel between Pfizer sites. NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS The position will requires approximately 20% travel